Novavax (NASDAQ:NVAX) shares fell on Tuesday after Citi started its coverage of the COVID shot maker with a Sell recommendation and a price target of $6, citing among other issues concerns over the ...

In the real world setting, when patients have to pay for their drugs out of their own pocket and without a rigorous reminder, ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

COVID-19 appears to be on the rise in some parts of California as a new, highly contagious subvariant — featuring “razor ...

All 17 members of ACIP, the Advisory Committee on Immunization Practices, have just published an article in JAMA (Journal of ...